WallStreetZenWallStreetZen

NASDAQ: SWTX
Springworks Therapeutics Inc Stock Ownership - Who owns Springworks Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Springworks Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Bhavesh AsharChief Commercial Officer2024-04-011,824$47.62
$86.86kSell
Daniel PichlChief People Officer2024-02-1615,000$50.10
$751.55kSell
Daniel PichlChief People Officer2024-02-1615,000$27.64
$414.60kBuy
Bhavesh AsharChief Commercial Officer2024-02-054,834$49.33
$238.44kSell
Daniel PichlChief People Officer2024-02-0214,175$44.31
$628.15kSell
Daniel PichlChief People Officer2024-02-0216,250$27.64
$449.15kBuy
Bhavesh AsharChief Commercial Officer2024-02-0288$46.37
$4.08kSell
Daniel PichlChief People Officer2024-02-029,266$43.81
$405.94kSell
Daniel PichlChief People Officer2024-02-02743$46.44
$34.51kSell
Daniel PichlChief People Officer2024-02-021,997$45.95
$91.76kSell

1 of 4

SWTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SWTX insiders and whales buy or sell their stock.

SWTX Shareholders

What type of owners hold Springworks Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC17.63%13,006,149$592.17MInsider
Fmr LLC14.65%10,809,235$492.14MInstitution
Freda C. Lewishall11.68%8,621,664$392.54MInsider
Stephen P. Squinto8.56%6,317,959$287.66MInsider
Vanguard Group Inc8.18%6,036,542$274.84MInstitution
Blackrock Inc7.29%5,382,184$245.05MInstitution
Bain Capital Life Sciences Investors LLC6.55%4,832,413$220.02MInsider
Pfizer Inc6.23%4,593,847$209.16MInsider
Deep Track Capital LP5.51%4,063,676$185.02MInstitution
Boxer Capital LLC4.64%3,421,541$155.78MInstitution

1 of 3

SWTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SWTX64.08%35.92%Net SellingNet Selling
AXSM71.00%29.00%Net SellingNet Buying
IOVA16.06%83.94%Net BuyingNet Buying
FTRE99.87%0.13%Net BuyingNet Selling
BHVN79.08%20.92%Net BuyingNet Buying
View Top Biotech Stocks

Springworks Therapeutics Stock Ownership FAQ

Who owns Springworks Therapeutics?

Springworks Therapeutics (NASDAQ: SWTX) is owned by 102.09% institutional shareholders, 57.23% Springworks Therapeutics insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Springworks Therapeutics shareholder, owning 13.01M shares representing 17.63% of the company. Orbimed Advisors LLC's Springworks Therapeutics shares are currently valued at $592.17M.

If you're new to stock investing, here's how to buy Springworks Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.